Ingevity Corporation (NGVT)

NYSE • Basic Materials

$69.64

-$0.2 (-0.3%)

Market open

Last close at October 23, 2026 at 20:00 UTC

Open$68.86

Previous Close$69.64

Day Range$68.43 - $70.04

Avg. Volume (3M)259.2K

Market Cap$2.3B

P/E Ratio45.2

52 Week Range

$45.85$79.29

Next EarningsIn 10 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$314.1M100%

Gross Profitminus cost of goods$139M44%

Operating Incomeminus R&D and overhead$60.1M19%

Net Incomeminus taxes and the rest$35.3M11%

In plain terms: out of every $100 in revenue, Ingevity Corporation keeps $11 as net profit.

Fundamentals & Financials

Revenue (TTM)

$1.1B

Net Income (TTM)

$54M

EPS (TTM)

$1.54

ROA (TTM)

3.51%

Current Ratio

1.61

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

+36.3%Q3 2025$1.39

+92.6%Q4 2025$1.31

-12.8%Q1 2026$0.58

+36.9%Q2 2026$1.15

+30.8%Q3 2026$1.74

Nov 4

in 10 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Beat +30.8%

Ingevity Corporation's adjusted EPS topped consensus and revenue edged past estimates in the second fiscal quarter of 2026, reported July 29, based on preliminary results, with adjusted EPS of $1.74 versus the $1.33 estimate and revenue of about $314.1 million versus $312.2 million, a 30.8% EPS beat and a 0.6% revenue beat. Revenue fell 14.0% from $365.1 million a year earlier, while gross profit came in at about $139.0 million and gross margin held near 44% on the quarter. The largest business, Performance Materials, generated about $155.4 million and rose 5.9%, keeping it the largest contributor to sales; adjusted EPS was up 25.2% from $1.39 a year ago. Operating cash flow was negative $13.8 million, and the company repurchased about $34.5 million of stock. Consensus for the next period calls for EPS of $1.58 on revenue of $305.4 million.

Next report — what to expect

Ingevity Corporation (NGVT) reports on November 4, 2026. Wall Street is looking for consensus EPS of $1.57 on consensus revenue of $303.9 million. For trailing context, revenue declined -14.0% year over year last quarter. NGVT has beaten EPS in 7 of 8 most recent quarters, a key track record to watch.

View full earnings history

About Ingevity Corporation

Ingevity Corporation (NYSE: NGVT) makes specialty chemical materials and advanced chemical solutions for industrial and consumer applications. The company operates in the chemicals business and generated $1.2 billion of revenue in FY2025. Its operations center on Performance Materials and Performance Chemicals, which together span activated carbon, pavement technologies, industrial specialty products, and engineered polymers.

Name

Ingevity Corporation

CEO

David H. Li

Website

www.ingevity.com

Industry

Basic Materials

Year Founded

1964

Employees

1,500

Today's Snapshot

AI-generated

NGVT closed slightly lower at 69.68. NGVT is due to report earnings on 4 November.

Trading Volume

Below 10d avg (243.5K)

176.4K

vs S&P 500 Today

Moderate Outperformance

+0.29%

Updated: October 23, 2026 at 20:08 UTC

Technical Indicators

1 Buy2 Neutral5 Sell

NGVT shows a weak technical setup that favors sellers: the stock sits below the classic pivot at 70.12 and under most short- and medium-term moving averages while the 200-day EMA lies slightly below price, creating a mixed timeframe picture. Momentum indicators are skewed negative with a deeply negative CCI and a slightly negative MACD, while RSI is subdued and ADX under 10 signals a lack of strong trend. Volatility is moderate and on-balance volume is positive but doesn’t offset the array of bearish averages. Technical takeaway: Sell.

All signals